Amitriptylinoxide
Amitriptylinoxide is a tricyclic antidepressant (TCA) that was developed in the late 1960s but was never marketed. It is the 10,11-dihydro derivative of amitriptyline.
Pharmacology[edit | edit source]
Amitriptylinoxide acts as a serotonin-norepinephrine reuptake inhibitor (SNRI) and also blocks the acetylcholine receptor, the latter of which is responsible for its anticholinergic side effects. It is less sedating and has less anticholinergic effect than amitriptyline.
Chemistry[edit | edit source]
Amitriptylinoxide, also known as 10,11-dihydro-N,N-dimethyl-5H-dibenzo[a,d]cycloheptene-Δ5,γ-oxide, is a tricyclic compound and is structurally related to other tricyclic antidepressants such as amitriptyline and nortriptyline.
See also[edit | edit source]
References[edit | edit source]
Amitriptylinoxide Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Admin, Prab R. Tumpati, MD